Inventor · disambiguated record
Kalyan Kathala
Also filed as: KATHALA KALYAN · KATHALA KALYAN KUMAR
25 granted patents·10 pending applications·424 citations·filing 2014–2025
96Inventor score
Top patents by PatentIndex Score
35 records- 0198US10857143B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2019·Granted Dec 8, 2020·45 cites·27 claims
- 0298US10507203B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2018·Granted Dec 17, 2019·42 cites·19 claims
- 0398US9844545B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2017·Granted Dec 19, 2017·43 cites·30 claims
- 0498US9844544B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2016·Granted Dec 19, 2017·46 cites·40 claims
- 0598US9545399B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2016·Granted Jan 17, 2017·50 cites·27 claims
- 0698US9295642B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2015·Granted Mar 29, 2016·61 cites·29 claims
- 0798US9180100B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2015·Granted Nov 10, 2015·55 cites·30 claims
- 0898US8999386B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2014·Granted Apr 7, 2015·56 cites·30 claims
- 0997US11103494B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2020·Granted Aug 31, 2021·5 cites·30 claims
- 1097US11103495B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2021·Granted Aug 31, 2021·5 cites·30 claims
- 1195US11433046B2Compositions and methods for treating epilepsy, seizures and other conditionsTULEX PHARMACEUTICALS INC·Filed 2021·Granted Sep 6, 2022·3 cites·17 claims
- 1294US11911362B2Compositions and methods for treating epilepsy, seizures and other conditionsTULEX PHARMACEUTICALS INC·Filed 2023·Granted Feb 27, 2024·1 cites·20 claims
- 1393US12343372B2Desmopressin oral compositionsTULEX PHARMACEUTICALS INC·Filed 2024·Granted Jul 1, 2025·2 cites·29 claims
- 1493US12214010B2Desmopressin oral compositionsTULEX PHARMACEUTICALS INC·Filed 2024·Granted Feb 4, 2025·2 cites·22 claims
- 1593US11826343B2Compositions and methods for treating epilepsy, seizures and other conditionsTULEX PHARMACEUTICALS INC·Filed 2023·Granted Nov 28, 2023·1 cites·19 claims
- 1693US11633374B2Compositions and methods for treating epilepsy, seizures and other conditionsTULEX PHARMACEUTICALS INC·Filed 2022·Granted Apr 25, 2023·2 cites·20 claims
- 1790US12133914B2Hydrocortisone oral liquid formulationsETON PHARMACEUTICALS INC·Filed 2024·Granted Nov 5, 2024·2 cites·20 claims
- 1888US12290503B2Compositions and methods for treating epilepsy, seizures and other conditionsTULEX PHARMACEUTICALS INC·Filed 2024·Granted May 6, 2025·0 cites·19 claims
- 1988US11904046B1Hydrocortisone oral liquid formulationsETON PHARMACEUTICALS INC·Filed 2023·Granted Feb 20, 2024·1 cites·30 claims
- 2087US2023233542A1Methylphenidate Extended Release Chewable TabletTRIS PHARMA INC·Filed 2023·Application pending·0 cites
- 2183US11590081B1Extended release amphetamine tabletsTRIS PHARMA INC·Filed 2018·Granted Feb 28, 2023·1 cites·37 claims
- 2283US11590228B1Extended release amphetamine compositionsTRIS PHARMA INC·Filed 2019·Granted Feb 28, 2023·1 cites·18 claims
- 2381US2025064747A1Extended release amphetamine tabletsTRIS PHARMA INC·Filed 2024·Application pending·0 cites
- 2480US12419831B2Hydrocortisone oral liquid formulationsETON PHARMACEUTICALS INC·Filed 2024·Granted Sep 23, 2025·0 cites·25 claims
- 2580US12076441B2Extended release amphetamine tabletsTRIS PHARMA INC·Filed 2023·Granted Sep 3, 2024·0 cites·6 claims
- 2680US2025275941A1Compositions and methods for treating epilepsy, seizures and other conditionsTULEX PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2777US11633389B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2020·Granted Apr 25, 2023·0 cites·30 claims
- 2873US2021169844A1Compositions and methods for treating epilepsy, seizures and other conditionsTULEX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2972US2017319566A1Methylphenidate Extended Release Chewable TabletTRIS PHARMA INC·Filed 2017·Application pending·0 cites
- 3072US2023233683A1Extended release amphetamine compositionsTRIS PHARMA INC·Filed 2023·Application pending·0 cites
- 3165US2025144106A1Ready to use non-aqueous solutions of lamotrigineTULEX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3261US2025134883A1Novel compositionsTULEX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3358US2024299307A1Extended-release compositions comprising atomoxetineTULEX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3453US12458592B1Extended release amphetamine tabletsTRIS PHARMA INC·Filed 2022·Granted Nov 4, 2025·0 cites·8 claims
- 3544US2022265566A1Atovaquone nanoparticulate compositionsTULEX PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kalyan Kathala files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →